AI Article Synopsis
- A framework is developed to automate the process of calculating daily dose distributions for proton therapy quickly enough for online evaluation using CT-on-Rails.
- Daily dose calculations utilize both rigid and deformable registration techniques to effectively align images and propagate risk structures.
- Results showed that the automated system completed daily evaluations with minimal discrepancies and fast processing times, proving useful for identifying changes that may impact treatment decisions.
Article Abstract
Purpose: To demonstrate a framework for calculating daily dose distributions for proton therapy in a timeframe amenable to online evaluation using CT-on-Rails.
Methods: Tasks associated with calculation of daily dose are fully automated. A rigid registration between daily and planning images is used to propagate beams and targets for calculation of daily dose; additionally, risk structures are propagated using deformable registration to facilitate online evaluation. An end-to-end constancy test was carried out using a pelvis phantom containing a simulated target and bladder contour. 97 Daily fan-beam CT data sets associated with 10 clinical patients were processed to demonstrate feasibility and utility of online evaluation. Computing times and dosimetric differences are reported.
Results: The phantom constancy test took 62 s to complete with no notable discrepancies in the registrations or calculated dose. Max doses were identical for target and bladder contours on initial and repeat scans (359 and 310 cGy (RBE) respectively). Total processing time for 97 daily patient images averaged 154.6 s (73.0 - 222.0 s; SD = 31.8 s). On average, dose calculation accounted for 35 % of total processing time. Average differences in D95 for target contours was 1.5 % (SD = 1.6 %) with a max decrease of 5.9 % on a single daily image.
Conclusion: Daily dose can be automatically calculated in a timeframe amenable to online evaluation using scanner utilities in conjunction with the scripting API of a commercial treatment planning system. Online evaluation of dose in proton therapy is useful to detect clinically relevant changes, guide setup, and facilitate treatment or replanning decisions.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ejmp.2024.103379 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Phase I Clinical Trial of High Doses of Seleno-L-methionine in Combination with Axitinib in Patients with Previously Treated Metastatic Clear Cell Renal Cell Carcinoma.
Clin Cancer Res
January 2025
Roswell Park Cancer Institute, Buffalo, NY, United States.
Background: Data in clear cell renal cell carcinoma (ccRCC) xenografts defined the seleno-L-methionine (SLM) dose and the plasma selenium concentrations associated with the enhancement of HIF1α/2α degradation, stabilization of tumor vasculature, enhanced drug delivery, and efficacy of axitinib. The data provided the rationale for the development of this phase I clinical trial of SLM and axitinib in advanced or metastatic relapsed ccRCC.
Patients And Methods: Patients were ≥18 years with histologically and radiologically confirmed advanced or metastatic ccRCC who had received at least one prior systemic therapy, which could include axitinib (last dose ≥6 months prior to enrollment).
A combination of gold nanoparticles and laser photobiomodulation to boost antioxidant defenses in the recovery of muscle injuries caused by Bothrops jararaca venom.
Lasers Med Sci
January 2025
Laboratory of Pathophysiology Experimental, Postgraduate Program in Health Sciences, Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC, Brazil.
Unlabelled: This study aimed to evaluate gold nanoparticles (GNPs) and photobiomodulation (PBM), associated with antibothropic serum (AS), to treat a muscle lesion induced by Bothrops jararaca venom.
Methods: 108 Swiss male mice were used, divided into nine groups (n = 12) with different combinations of treatments. Animals were inoculated with 250 µg of B.
The Effectiveness of Budesonide Once Daily as Maintenance Treatment of Eosinophilic Esophagitis.
J Clin Gastroenterol
January 2025
Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.
Background: Swallowed topical corticosteroids (STC) are an effective first-line therapy for patients with eosinophilic esophagitis (EoE), both for induction and maintenance of remission. All interventional trials with STC used twice-daily dosing regimens. However, in other inflammatory gastrointestinal disorders, corticosteroids are given once daily (OD) with equal outcomes and improved compliance.
View Article and Find Full Text PDFObjectives The optimal dosing schedule strategy for granulocyte colony-stimulating factor (G-CSF) in healthy stem cell donors remains controversial. This study aimed to compare the efficacy of once-daily versus twice-daily G-CSF administration in allogeneic stem cell donors. Materials and methods We retrospectively analyzed data from 388 healthy unrelated donors (282 males, 106 females) who underwent stem cell mobilization at our center between September 2018 and June 2022.
View Article and Find Full Text PDFGlycemic variability and quality of life outcomes after changing to hybrid closed-loop system in Japanese individuals with type 1 diabetes using a conventional predictive low-glucose suspended insulin pump system.
Diabetol Int
January 2025
Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Toho University Graduate School of Medicine, 6-11-1 Omori-Nishi, Ota-ku, Tokyo 143-8541 Japan.
Unlabelled: The hybrid closed-loop (HCL) system, Medtronic MiniMed 770G, has been available for use by Japanese individuals with type 1 diabetes mellitus since 2021. The aim of this study was to evaluate the effect of its use on glycemic variability and quality of life (QOL) in this population. This multicenter, open-label, prospective observational study included 14 Japanese individuals with type 1 diabetes mellitus treated with MiniMed 640G.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!